课题基金 / 基金详情

BENIGN BLADDER DISEASE AND MITOCHONDRIAL FUNCTION

BENIGN BLADDER DISEASE AND MITOCHONDRIAL FUNCTION
良性膀胱疾病和线粒体功能
批准号:
2905621
负责人:
ALAN PAUL HUDSON
金额:
$13.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-07-26 至 2001-06-30

项目摘要

项目成果

ALAN PAUL HUDSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Partial bladder obstruction secondary to benign prostatic hyperplasia is associated with increased bladder mass, alterations in bladder capacity, in bladder compliance and in in vitro responses to pharmacological stimulations. In the rabbit, the obstruction-induced changes in the bladder mass and function stabilized after 14 days. In the compensated period, alterations in biochemical parameters such as lactic acid, CO2 production and pyruvate metabolism and Krebs cycle enzyme activities indicate that mitochondrial energy production is affected. While physiological and biochemical changes of the obstructed bladder have been characterized, few studies of molecular mechanisms underlying these alterations have been attempted. The investigators have shown that in the first 14 days post obstruction, the relative number of copies of the mitochondrial genome decreases by 10-fold in the rabbit bladder; while TCA cycle enzymes decline in activity, cytochrome oxidase does not. Furthermore, although mitochondrial genome copy number decreases, mitochondrial transcript remains near normal, suggesting an upregulation of mitochondrial transcription in the compensated period. In the present proposal, the investigators plan to define alterations in expression for mitochondrial and nuclear genes during the compensated and decompensated periods after partial obstruction in rabbit. They also plan to correlate the molecular findings with urodynamic status, bladder mass, and the contractile responses to autonomic agonists, field stimulation and KCl. These studies will increase understanding of the molecular basis for bladder dysfunction after obstruction and may provide useful information for designing new therapeutic tools.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
Effects of atropine, isoproterenol and propranolol on the rabbit bladder contraction induced by intra-arterial administration of acetylcholine and ATP.
阿托品、异丙肾上腺素和普萘洛尔对动脉注射乙酰胆碱和 ATP 诱导的家兔膀胱收缩的影响。
DOI: --
发表时间: 1998
期刊: The Journal of urology.
影响因子: --
作者: [Liu,SP, Horan,P, Levin,RM]
通讯作者: Levin,RM
Rabbit versus rat urinary bladder: effects of in vitro hypoxia.
兔子与大鼠膀胱:体外缺氧的影响。
DOI: 10.1159/000028316
发表时间: 1999
期刊: Pharmacology
影响因子: 3.1
作者: [Whitbeck,C, Barreto,M, Horan,P, Levin,SS, Levin,RM]
通讯作者: Levin,RM
DOI: 10.1097/01.ju.0000129560.25005.0e
发表时间: 2004-08
期刊: The Journal of urology
影响因子: --
作者: [R. Levin;A. Hudson]
通讯作者: R. Levin;A. Hudson
Metabolic aspects of urinary bladder filling.
膀胱充盈的代谢方面。
DOI: 10.1080/003655999750042169
发表时间: 1999
期刊: Scandinavian journal of urology and nephrology. Supplementum
影响因子: --
作者: [Levin,RM, Horan,P, Liu,SP]
通讯作者: Liu,SP
22
    CHLAMYDIA PNEUMONIAE--A PATHOGEN IN ALZHEIMERS DISEASE
    • 批准号:
      2901888
    • 项目类别:
    • 资助金额:
      $28.69万
    • 财政年份:
      1999
    • 负责人:
      ALAN PAUL HUDSON
    • 依托单位:
    CHLAMYDIA PNEUMONIAE--A PATHOGEN IN ALZHEIMERS DISEASE
    • 批准号:
      6511143
    • 项目类别:
    • 资助金额:
      $29.1万
    • 财政年份:
      1999
    • 负责人:
      ALAN PAUL HUDSON
    • 依托单位:
    CHLAMYDIA PNEUMONIAE--A PATHOGEN IN ALZHEIMERS DISEASE
    • 批准号:
      6374003
    • 项目类别:
    • 资助金额:
      $28.25万
    • 财政年份:
      1999
    • 负责人:
      ALAN PAUL HUDSON
    • 依托单位:
    CHLAMYDIA PNEUMONIAE--A PATHOGEN IN ALZHEIMERS DISEASE
    • 批准号:
      6170675
    • 项目类别:
    • 资助金额:
      $27.43万
    • 财政年份:
      1999
    • 负责人:
      ALAN PAUL HUDSON
    • 依托单位:
    海外基金